December 19, 2016
Veloxis increases capital by 1,5M new shares
Danish pharmaceutical company Veloxis Pharmaceuticals A/S, has increased its capital by 1,500,000 new shares. The company said on Monday that…
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
December 19, 2016
Chinese AceCGT bags distribution deal with Belgian MDxHealth for prostate cancer assay in Hong Kong and Macao
MDxHealth has signed a distribution agreement with AceCGT Life Science Limited for their SelectMDx for Prostate Cancer assay in Hong Kong…
December 19, 2016
ADA updates recommendation for Lilly’s type 2 diabetes drug
The American Diabetes Association (ADA) has included new recommendation about the use of Jardiance tablets for type 2 diabetes patients…
December 19, 2016
Janssen asks FDA’s permission to treat adolescent plaque psoriasis patients with Solara
Janssen Biotech is looking to expand the usage of its prescription drug Stelara, as it has asked the U.S. Food…
December 16, 2016
Lilly/Incyte’s rheumatoid arthritis drug gets CHMP’s recommendation for EMA’s approval
Eli Lilly and Incyte Corporation have gotten positive opinion from European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…
December 16, 2016
Mylan Launches generic for EpiPen adrenaline injection, fights rising US drug prices
Mylan is launching its generic for EpiPen adrenaline injection at a wholesale acquisition cost (WAC) of $300 per epinephrine injection. As…
December 16, 2016
Novartis’s epilepsy drug gets CHMP’s positive opinion
Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for…
December 16, 2016
ABIVAX welcomes Didier Blondel as CFO
ABIVAX has appointed Didier Blondel as Chief Financial Officer, effective January 2nd, 2017.
December 16, 2016
FDA OK’s Cerenis’s CER-209 clinical trial for liver disease treatment
U.S. Food and Drug Administration (FDA) has given green light to Cerenis Therapeutics to proceed with CER-209 clinical trial.
December 16, 2016
Novartis buys Ziarco Group
Novartis has entered into a definitive agreement to buy a privately held company Ziarco Group Limited, focused on producing dermatology…